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Protein Expression and Purification for NMR Experiments
All ETV6 fragments used for the NMR experiments were expressed in frame with an Nterminal His 6 -affinity tag and a thrombin cleavage site. The appropriate segments of the murine ETV6 gene (NP_031987) were cloned via PCR methods into a pET28b+ vector (Novagen) utilizing NdeI and HindIII restriction sites at the 5' and 3' ends, respectively.
The resulting plasmids were transformed into E. coli BL21 (λDE3) cells for protein expression. The pET28b+ vector provides kanamycin resistance and all media contained 70 mg/L of this antibiotic. In each case, an overnight culture in LB media was prepared using either a fresh transformant or a glycerol stock stored at -80 o C. The 25 mL culture was pelleted by centrifugation at 3,000 rpm for 10 min, resuspended in sterile water, and used to inoculate 1 L of M9 media supplemented with 3 gm 13 C 6 -glucose and/or 1 gm of 15 NH 4 Cl (Sigma-Aldrich or Cambridge Isotope Laboratories), as appropriate. This was grown in shaker flasks at 37 o C, and when the OD 600 reached 0.6, protein expression was induced with 1 mM IPTG. After further growth at 30 o C for 6-9 hours, the cells were collected by centrifugation in a Sorvall GSA rotor at 4,000 rpm, washed by resuspension with 0.25 M sucrose, split into two 50 mL disposable media tubes, spun again at 4,000 rpm, and stored at -80 o C for future purification.
The cell pellet resuspended in 40 mL per tube of lysis buffer (100 mM Tris pH 8.2, 1 M NaCl, 20 mM imidizole, 5 mM tris(2-carboxyethyl)phosphine (TCEP), and 2-5 mM fresh phenylmethanesulfonylfluoride (PMSF) and stored on ice. Once thawed, the cells were disrupted by 5 cycles of sonication (1 min at full power and 1 min on cooling on ice) using a Branson Sonifer 250, followed by centrifugation for 30 min in a Sorvall SS34 rotor at 10,000 rpm. The clarified solution was loaded on to a 5 mL HP-FF Ni +2 -NTA resin column (GE Healthcare) and washed with 30 mL of wash buffer (100 mM Tris pH 8.2, 20 mM imidizole, 200 mM NaCl, 1 mM TCEP). The His 6 -tagged protein was eluted using a 20-column volume gradient to 100% elution buffer (100 mM Tris pH 8.2, 1 M imidizole, 200 mM NaCl, 1 mM TCEP). The eluent was monitored at 280 nm while collecting 3 mL fractions. Fractions that exhibited a high absorbance were assessed for purity by SDS-Tricine gel electrophoresis. The highest purity S3 fractions were pooled, concentrated and exchanged by ultrafiltration with an Amicon 3 kDa MWCO concentrator into thrombin cleavage buffer (50 mM phosphate pH 8.0, 150 mM NaCl).
The amount of protein was determined by UV absorbance, utilizing its predicted molar absorptivity (http://web.expasy.org/protparam/). The His 6 -affinity tag was cleaved by overnight incubation with thrombin at room temperature with constant inversion. Affinity tag cleavage was deemed complete as determined by MALDI-TOF mass spectrometry, using 3,5-dimethoxy-4-hydroxycinnamic acid as the matrix. The resulting proteins, with four additional non-native Nterminal residues (Gly-Ser-His-Met), are denoted as ETV6 R426 (residues Arg335-Arg426),
D446' (Gly329-Asp446), and ETV6 R458 (Arg335-Arg458). In the cases of ETV6 R426' and ETV6 D446' , Cys334 was mutated to serine to prevent oxidation problems.
Once His 6 -tag cleavage was confirmed, p-aminobenzamidine beads (3 mg protein : 250 µL beads) were added to remove the thrombin protease. The solution was mixed by inversion for at least 1 hr at room temperature, and the beads removed by centrifugation at 3,000 rpm for 10 min using a Beckman table top centrifuge. The solution was concentrated to 2-3 mL using an Amicon 3 kDa MWCO concentrator, and then loaded onto a Superdex 75 gel filtration column (2.6 cm diameter, 70 cm length; GE Healthcare). The protein sample was eluted with Gel Filtration Buffer (50 mM phosphate pH 5.8, 200 mM NaCl) at 2 mL/min. The eluent was monitored at 280 nm while collecting 2 mL fractions. The highest purity fractions, as assessed by SDS-tricine gel electrophoresis, were pooled and concentrated with buffer adjustment using an Amicon 3K Da MWCO concentrator. Final protein yields averaged about 6 mg per litre of M9 media, with ETV6 Q436 produced in the greatest amount. Towards the end of this study, it was found that yields could be increased ~2-fold by including 3M guanidinium chloride in the Lysis Buffer, and allowing refolding of the Ni +2 -NTA resin-bound protein during the wash step.
Unless stated otherwise, the NMR samples were prepared in a final volume of 300 -600
µL at a concentration of 0.4 to 0.6 mM in sample buffer (50 mM phosphate, 200 mM NaCl, pH 5.8). To prevent any possible proteolytic degradation, 1 µL of EDTA Free Roche inhibitor S4 solution (prepared by dissolving 1 tablet in 1 mL of gel filtration buffer) was also added per 50 µL NMR sample.
Protein Expression and Purification for EMSA Experiments
The plasmids were transformed into E. coli BL21 (λDE3) cells for protein expression. In each case, one liter of L-Broth, including kanamycin (100 µg/ml) for pET28b+ vector selection, was inoculated with an overnight culture. Cells were grown to an OD 600 of 0.8 and induced with 1 mM IPtG for 2 hours. The cell pellet was resuspended in 30 mL of cold 25 mM Tris-Cl pH 7.9, 1 M NaCl, 1 mM EDTA, 1 mM DTT, 1 mM phenylmethlysulfonyl fluoride, and 10 mM imidazole. This pellet was then lysed by sonication on ice and followed by centrifugation at 180,000 g for 45 min. The clarified supernatant was loaded onto four interlocked 5 mL HisTrap FF column (GE Healthcare) and washed with HisTrap Buffer (25 mM Tris-Cl pH 7.9, 1M NaCl, 0.1 mM EDTA, 1 mM BME) at 10 mM imidazole. The protein was eluted by a gradient up to 500 mM imidazole in HisTrap elution buffer. The eluent was monitored at 280 nm and the appropriate peak collected and dialyzed overnight at 4 o C against Dialysis Buffer (20mM sodium citrate pH 5.3, 150 mM KCl, 1mM EDTA, 1mM DTT, 0.2mM PMSF and 10% glycerol).
Simultaneously, the His 6 -affinity tag was cleaved by adding 12 units of thrombin and adjusting the Dialysis Buffer to 2.5 mM CaCl. The protein was chromatographed through tandem DEAE resin and 5 mL S-Sepharose SPHP (GE healthcare) columns in the Dialysis Buffer. The ETV6, which flowed through the anion exchange column and bound the cation exchange column, was eluted by a linear gradient between 150 and 650 mM KCl in Dialysis Buffer. The ETV6 peak, monitored at 280 nm, eluted at approximately 500 mM KCl. After assessment by SDS-PAGE, the peak fractions were pooled then concentrated by Amicon 3kD MWCO filtration and loaded on a Superdex 75 column (2.6 cm diameter, 60 cm length; GE Healthcare) in buffer (20 mM sodium citrate pH 5.3, 500 mM KCl, 1 mM EDTA, 1 mM DTT, 0.2 mM PMSF and 10% glycerol). Purified protein, estimated >95% purity, was stored at -80 o C in 30 μL aliquots for one-time use. (PF R458)   R335  L345  R355  R365  L375  M385  R395  K405  F415  G425  S435  G455  E445   H1  H3  H2  S1 S2 S3 S4 H4 H5 lifetimes, as seen for the disordered C-terminal tails of the two proteins, reflect enhanced mobility on the nsec-psec timescale. In contrast, short T 2 lifetimes, as exhibited by residues spanning helix H3 to strand S3 in uninhibited ETV6 R426 but not inhibited ETV6 R458 , result from conformational exchange broadening on the msec-µsec timescale. This exchange is best quantitated using the relaxation dispersion experiments presented in Fig. 6 (carbon, yellow) and GABPA (carbon, orange). Middle: the structure of ETS1 (1R36.pdb) with key residues (yellow) shown with the modeled corresponding side chains of ETV6 (green).
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Bottom: the structure of GABPA (1AWC.pdb) with key residues (orange) shown with the modeled corresponding side chains of ETV6 (green). The helices and strands of the ETS domains are in red cartoon format, and the appended helices in cyan. In each case, Swiss-Model {Arnold, 2006 #149} was used to "mutate" the sequence of one ETS family member into the experimentally determined structure of the other member.
Note that the locations of the appended helices likely depend upon the combined positive, neutral, and negative effects of several amino acids within the context each possible structure, rather than on one signal lynchpin residue. That is, in any particular case, the amino acid differences may favor or disfavor one structure, whereas the reverse change may be relatively neutral. For example, substitution of the exposed Lys362 in the structure of ETV6 R458 with the corresponding tryptophan of ETS1 or glycine of GABPA would likely be tolerated, but the reciprocal substitution of the buried Trp361 in ETS1 with a lysine of ETV6 would be not be favorable. Thus, the sequence at this particular position would disfavor ETV6 from adopting the ETS1 fold, but not visa versa. However, changes at other positions would disfavor ETS1 from folding as ETV6.
